| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biophys J, June 2000, p. 2892-2899, Vol. 78, No. 6


*Research Institute of Neurodegenerative Diseases, Sendai 980-0871;
Department of Physiology, Tohoku University School of
Medicine, Sendai 980-0972;
Institute for Chemical
Research, Kyoto University, Uji 611-0011; §Graduate School
of Material Science, Nara Institute of Science and Technology, Ikoma
630-0101; and ¶Suntory Institute for Bioorganic Research,
Osaka 618-8503, Japan
We report that long-chain poly-L-glutamine
forms cation-selective channels when incorporated into artificial
planar lipid bilayer membranes. The channel was permeable to alkali
cations and H+ ions and virtually impermeable to anions;
the selectivity sequence based on the single-channel conductance was
H+
Cs+ > K+ > Na+. The cation channel was characterized by long-lived
open states (often lasting for several minutes to tens of minutes)
interrupted by brief closings. The appearance of the channel depended
critically on the length of polyglutamine chains; ion channels were
observed with 40-residue stretches, whereas no significant conductance changes were detected with 29-residue tracts. The channel-forming threshold length of poly-L-glutamine was thus between 29 and 40 residues. A molecular mechanics calculation suggests a µ-helix (Monoi, 1995. Biophys. J. 69:1130-1141) as a candidate
molecular structure of the channel. The channel-forming nature of
long-chain poly-L-glutamine may provide a clue to the
elucidation of the pathogenetic mechanism of the polyglutamine
diseases, a group of inherited neurodegenerative disorders including
Huntington's disease.
Biophys J, June 2000, p. 2892-2899, Vol. 78, No. 6
© 2000 by the Biophysical Society 0006-3495/00/06/2892/08 $2.00
This article has been cited by other articles:
![]() |
S. J. Singer and N. N. Dewji Evidence that Perutz's double-beta-stranded subunit structure for beta-amyloids also applies to their channel-forming structures in membranes PNAS, January 31, 2006; 103(5): 1546 - 1550. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Michalik and C. Van Broeckhoven Pathogenesis of polyglutamine disorders: aggregation revisited Hum. Mol. Genet., October 15, 2003; 12(90002): R173 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. C. Tsai, P. S. Fishman, N. V. Thakor, and G. A. Oyler Parkin Facilitates the Elimination of Expanded Polyglutamine Proteins and Leads to Preservation of Proteasome Function J. Biol. Chem., June 6, 2003; 278(24): 22044 - 22055. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dedeoglu, J. K. Kubilus, T. M. Jeitner, S. A. Matson, M. Bogdanov, N. W. Kowall, W. R. Matson, A. J. L. Cooper, R. R. Ratan, M. F. Beal, et al. Therapeutic Effects of Cystamine in a Murine Model of Huntington's Disease J. Neurosci., October 15, 2002; 22(20): 8942 - 8950. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |